These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6107936)

  • 1. LDS-25 as a discriminative stimulus for response selection by pigeons.
    Järbe TU
    Pharmacol Biochem Behav; 1980 Oct; 13(4):549-54. PubMed ID: 6107936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminative stimulus properties of lysergic acid diethylamide in the monkey.
    Nielsen EB
    J Pharmacol Exp Ther; 1985 Jul; 234(1):244-9. PubMed ID: 4009503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminative stimulus properties of d-amphetamine in pigeons.
    Järbe TU
    Pharmacol Biochem Behav; 1982 Oct; 17(4):671-5. PubMed ID: 6294675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psilocybin as a discriminative stimulus: lack of specificity in an animal behavior model for 'hallucinogens'.
    Koerner J; Appel JB
    Psychopharmacology (Berl); 1982; 76(2):130-5. PubMed ID: 6805022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysergic acid diethylamide (LSD) as a discriminative cue: drugs with similar stimulus properties.
    Schechter MD; Rosecrans JA
    Psychopharmacologia; 1972; 26(3):313-6. PubMed ID: 5073050
    [No Abstract]   [Full Text] [Related]  

  • 6. Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline.
    Callahan PM; Appel JB
    J Pharmacol Exp Ther; 1988 Sep; 246(3):866-70. PubMed ID: 2901488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the stimulus properties of barbital and hallucinogens.
    Hirschhorn ID; Winter JC
    Pharmacol Biochem Behav; 1975; 3(3):343-7. PubMed ID: 1153438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the MDA and MDMA optical isomers in a stimulant-hallucinogen discrimination.
    Baker LE; Taylor MM
    Pharmacol Biochem Behav; 1997 Aug; 57(4):737-48. PubMed ID: 9259001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Hydroxytryptamine (serotonin)2A receptors in rat anterior cingulate cortex mediate the discriminative stimulus properties of d-lysergic acid diethylamide.
    Gresch PJ; Barrett RJ; Sanders-Bush E; Smith RL
    J Pharmacol Exp Ther; 2007 Feb; 320(2):662-9. PubMed ID: 17077317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug effects on the repeated generalization of a visual discrimination acquired under one trial per day conditions.
    Nielsen EB; Rolandi W; Appel JB
    Psychopharmacology (Berl); 1984; 82(3):233-6. PubMed ID: 6425906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Training dose as a factor in LSD-saline discrimination.
    White FJ; Appel JB
    Psychopharmacology (Berl); 1982; 76(1):20-5. PubMed ID: 6805003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of serotonin depletion on the discriminability of LSD.
    White FJ; Simmons MA; West KB; Holohean AM; Appel JB
    Pharmacol Biochem Behav; 1980 Oct; 13(4):569-74. PubMed ID: 6449014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative stimulus properties of cocaine. Effects of apomorphine, haloperidol, procaine and other drugs.
    Järbe TU
    Neuropharmacology; 1984 Aug; 23(8):899-907. PubMed ID: 6090966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of 5-HT receptor subtypes in the discriminative stimulus properties of mescaline.
    Appel JB; Callahan PM
    Eur J Pharmacol; 1989 Jan; 159(1):41-6. PubMed ID: 2707301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drugs and visual perception: effects of LSD, morphine and chloropromazine on accuracy, bias and speed.
    West KB; Hernandez LL; Appel JB
    Psychopharmacology (Berl); 1982; 76(4):320-4. PubMed ID: 6812104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LSD mescaline and serotonin injected into medial raphe nucleus potentiate apomorphine hypermotility.
    Fink H; Oelssner W
    Eur J Pharmacol; 1981 Nov; 75(4):289-96. PubMed ID: 7318915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cueing effects of amphetamine and LSD: elicitation by direct microinjection of the drugs into the nucleus accumbens.
    Nielsen EB; Scheel-Krüger J
    Eur J Pharmacol; 1986 Jun; 125(1):85-92. PubMed ID: 3732394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological and behavioral components of tolerance to LSD and mescaline in rats.
    Murray TF; Craigmill AL; Fischer GJ
    Pharmacol Biochem Behav; 1977 Sep; 7(3):239-44. PubMed ID: 928480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The stimulus properties of para-methoxyamphetamine: a nonessential serotonergic component.
    Winter JC
    Pharmacol Biochem Behav; 1984 Feb; 20(2):201-3. PubMed ID: 6546992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants.
    Ley L; Holze F; Arikci D; Becker AM; Straumann I; Klaiber A; Coviello F; Dierbach S; Thomann J; Duthaler U; Luethi D; Varghese N; Eckert A; Liechti ME
    Neuropsychopharmacology; 2023 Oct; 48(11):1659-1667. PubMed ID: 37231080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.